| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_08f57f2c0740d9528dece505b9bc61a4 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N5-0647
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-545
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-28 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-28 |
| filingDate |
2019-07-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9a7f732f3f4f614dc8c2ce42af309bbb
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_71a111a8c3871445600ec9a58e1d7b4f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_edef0fad6fb3b481401ef92c98aab0d7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f4571ddc6ca4290a6450d88698ee0387
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8fd7ebe463d258d63b7d20879ed68b04 |
| publicationDate |
2020-03-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2020021536-A9 |
| titleOfInvention |
Mitochondrial augmentation therapy for primary mitochondrial diseases |
| abstract |
The present invention provides human stem cells enriched with functional mitochondria, wherein the healthy functional exogenous mitochondria constitute at least 3% and less than 33% of the total mitochondria in the mitochondrially-enriched human stem cells. Further disclosed are methods for the production of such cells, and uses thereof for the treatment of primary mitochondrial diseases. |
| priorityDate |
2018-07-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |